Choose ALUNBRIG® (brigatinib): Helpful Resources
HCP Resources
Dosing Guide
Helpful information on the one-tablet, once-daily recommended dosage, and modifications for adverse reactions
Treating ALK-Positive Brochure
Expert opinions from a nurse practitioner about first-line treatment with ALUNBRIG for patients with ALK+ mNSCLC
Access Guide
At-a-glance distribution details and supply information as well as ordering options
Real Patient Case Studies
Real Patient Case Study: Katie
Learn about Katie’s treatment journey and her results with first-line ALUNBRIG
Real Patient Case Study: Greg
Learn about Greg's treatment journey and his response to first-line ALUNBRIG
Patient Resources
Patient Brochure
Information to help patients understand their treatment with ALUNBRIG
Patient Treatment Guide
Information to help patients start and stay on treatment with ALUNBRIG
Care Partner Brochure
A guide for care partners on how to best offer support for people starting ALUNBRIG
Shared
Decision-Making Guide
A guide to help patients participate in shared decision-making when determining their treatment plan
Connect With Our Team
Learn more about first-line ALUNBRIG for patients with ALK+ mNSCLC from an ALUNBRIG representative.
ALK, anaplastic lymphoma kinase; ALK+, ALK-positive; mNSCLC, metastatic NSCLC; NSCLC, non-small cell lung cancer.